|
2012 US MEDTECH CEO Forum
(Sixth Edition)
THE PROGRAM IS CURRENTLY OFFERED AND IS SEEKING FOR PARTNERS
June 2012 or December 2012, Boston, Minneapolis, Princeton, New York, USA
Rationale:
The United States is a the first Global Market market for providers of Medical Technologies, and it represents half of the $336 B market opportunity. 16 of thr Top25 Medical Technology Companies are based in the USA, and are geographically located in the Minneapolis and New Jersey states which are the target destination for this foreing trade development program.
Opportunity and Target Audience:
This Sixth edition of the US FORUMS will offer a unique combination of workshops and customized one-on-one business development meetings. Preparatory audits and workshops in Austria will start five months before the "in-coutry" program, following a selective recruitment process. Participants are decision makers (CEOs, CTOs and Business Development leaders) of established mid-size companies who are preparing their US market entry (with an existing validated service offering in their home country).
High Level program:
Interacting with the premier MedTech Ecosystems in the USA:
1.5 Days of targeted workshops..... with high profile Key Note speakers and hands-on discussions
2 Executive Dinner... with prominent Industry Associations from the Minnesota and New Jersey Pharma ecosystems
Participation to the MedTEch Industry Events (to be defined)
+ 30 Qualified Partnership Meetings... with targeted US corporations or Clinical Institutions (list is confidential)
|
|
2011 US-MEDTECH Forum
(Fith Edition)
In partnership with MONTPELLIER AGGLOMERATION, France
December 5-9, 2011, Minneapolis, Princeton, New York, USA
Rationale:
The United States is a the first Global Market market for providers of Medical Technologies, and it represents half of the $336 B market opportunity. 16 of thr Top25 Medical Technology Companies are based in the USA, and are geographically located in the Minneapolis and New Jersey states which are the target destination for this foreing trade development program.
Opportunity and Target Audience:
This fith edition of the US FORUMS will offer a unique combination of workshops and customized one-on-one business development meetings. Preparatory audits and workshops in Austria will start five months before the "in-coutry" program, following a selective recruitment process. Participants are decision makers (CEOs, CTOs and Business Development leaders) of established mid-size companies who are preparing their US market entry (with an existing validated service offering in their home country).
High Level program:
Interacting with the MedTech Ecosystems of Minneaopolis, New Jersey and New York....
1.5 Days of targeted workshops..... with high profile Key Note speakers and hands-on discussions
2 Executive Dinner... with prominent Industry Associations from the Minnesota and New Jersey Pharma ecosystems
Participation to the MedTEch LifeScience Alley Industry Annual Meeting
+ 30 Qualified Partnership Meetings... with targeted US corporations or Clinical Institutions (list is confidential)
|
In collaborating with the Global Cardiovascular Innovation Center and the Cleveland Clinic,
MedNest is proud to offer the
2011 US CARDIOVASCULAR Forum
(Fith Edition)
Satellite Session of the
2011 Medical Innovation Summit at the CLeveland Clinic
Cleveland, October 3-5, 2011
Rationale:
Estimated at more than $475 billion, cardiovascular medicine is the largest healthcare market opportunity in the US. The cardiovascular disease burden poses clear medical, scientific, and commercial challenges. In collaboration with the Global Cardiovascular Innovation Center (GCIC) and the Cleveland Clinic, MedNest is building international partnerships to facilitate the development and adoption of new cardiovascular technologies geared towards improving patient care. Cardiovascular research and commercialization – along with millions of patients – will benefit from the progress made through companies participating to this program.
Program Profile
The 2011 Cardiovascular Forum will give the opportunity to European Companies to participate to a program dedicated to set the foundation of their growth in the USA at the Global Cardiovascular Innovation Center. This International Program will leverage and include the participation to the high-profile “State of the Heart” Cleveland Clinic 2011 Medical Innovation Summit, which is dedicated to Cardiovascular Technologies in 2011.
High Level program:
1 Days of targeted workshops....to help US market Entry. with high profile Key Note speakers and hands-on discussions
Participation to the 2011 Medical Innovation Summit at the Cleveland Clinic
2 Executive Dinner... with prominent Industry Associations from the Ohio ecosystem, Cleveland Clinic
Qualified Partnership Meetings... with targeted US corporations or Cleveland Clinic Departments
Will speak at the 2011 Cleveland Clinic Innovation Summit….
Dick Cheney, Former US Vice President
Delos Cosgrove, MD Chief Executive Officer and President Cleveland Clinic
J. Raymond Elliott, Chief Executive Officer, Boston Scientific
Richard Gilfillan, MD, Acting Director, Center for Medicaid and Medicare Innovation
Howard Hutchinson, MD, Chief Medical Officer, AstraZeneca
Jeffrey Immelt, Chief Executive Officer, GE & Chair, President's Council on Jobs & Competitiveness
Bernard Lyons, PhD, Chief Executive Officer, Direct Flow Medical
Bruce Lytle, MD Chair, Heart and Vascular Institute, Cleveland Clinic
Clive Meanwell, Chief Executive Officer, The Medicines Company
Michael Mussallem, Chief Executive Officer, Edwards Lifesciences
Ferolyn Powell, Divisional Vice President & General Manager, Structural Heart, Abbott Vascular
Ian Read, Chief Executive Officer, Pfizer
Harry Rein, General Partner, Foundation Medical Partners
Michael Roizen, MD, Chief Wellness Officer, Cleveland Clinic
Michael Rosenblatt, MD, Chief Medical Officer, Merck
David Snow, Chief Executive Officer, Medco
Dan Starks, Chief Executive Officer, St. Jude Medical
Murat Tuzcu, MD, Vice Chair, Cardiovascular Medicine, Cleveland Clinic
Bram Zuckerman, MD, Director, Division of Cardiovascular Devices, US, Food and Drug Administration
About Cleveland Clinic
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. It was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. About 2,800 full-time salaried physicians and researchers and 11,000 nurses represent 120 medical specialties and subspecialties. In 2010, there were 4 million visits throughout the Cleveland Clinic health system and 155,000 hospital admissions.
About the Global Cardiovascular Innovation Center
The Global Cardiovascular Innovation Center (GCIC) is a cardiovascular product development consortium made possible through a $60 million grant from the State of Ohio’s Third Frontier Program. Founded in 2007, GCIC is the first Wright Mega-Center of Innovation under this program. GCIC is focused on the formation, attraction, expansion and retention of cardiovascular companies to create jobs and facilitate economic development in the State of Ohio.
|
|
2011 US-AUSTRIA MEDTECH Forum
(Fourth Edition)
In partnership with ADVANTAGE AUSTRIA
December 5-9, 2011, Minneapolis, Princeton, New York, USA
Rationale:
The United States is a the first Global Market market for providers of Medical Technologies, and it represents half of the $336 B market opportunity. 16 of thr Top25 Medical Technology Companies are based in the USA, and are geographically located in the Minneapolis and New Jersey states which are the target destination for this foreing trade development program.
Opportunity and Target Audience:
This fouth edition of the US FORUMS will offer a unique combination of workshops and customized one-on-one business development meetings. Preparatory audits and workshops in Austria will start five months before the "in-coutry" program, following a selective recruitment process. Participants are decision makers (CEOs, CTOs and Business Development leaders) of established mid-size companies who are preparing their US market entry (with an existing validated service offering in their home country).
High Level program:
Interacting with the MedTech Ecosystems of Minneaopolis, New Jersey and New York....
1.5 Days of targeted workshops..... with high profile Key Note speakers and hands-on discussions
2 Executive Dinner... with prominent Industry Associations from the Minnesota and New Jersey Pharma ecosystems
Participation to the MedTEch LifeScience Alley Industry Annual Meeting
+ 30 Qualified Partnership Meetings... with targeted US corporations or Clinical Institutions (list is confidential)
|
|
2011 US PHARMA SERVICES Forum
(Third Edition)
June 13-17 2011, Princeton, Philadelphia, New York, USA
Rationale:
With an estimated size of $340Billion, the US Pharmaceutical Market represents more than 50% of the world wide market. It is growing at a 4-6% rate. In this market, more than 20% of the pharmaceutical industry has increased their outsourcing budgets by more than 10% in 2010. In particular, virtual Pharma, Emerging Pharma and Top Pharma companies drive the outsourcing trend with services ranging from R&D, to QA/QC services.
The United States pharmaceutical industry is a major market for providers of services, but one should not underestimate the dynamics of this market, its segmentation complexity and extremely intense competitive environment. There are multiple opportunities from companies offering services that are differentiated with Technology, outstanding personnel and strong operating and quality protocols.
Opportunity and Target Audience:
This third edition of the US PHARMA SERVICES Forum will address these challenges through combination of Workshops and customized one-on-one business development meetings. Participants are decision makers (CEOs, CTOs and Business Development leaders) of established mid-size companies who are preparing their US market entry (with an existing validated service offering in their home country).
High Level program:
Visiting the Pharmaceutical Ecosystems of Pensylvania, New York State and New Jersey...
2 Days of targeted workshops..... with high profile Key Note speakers and hands-on discussions
2 Executive Dinner... with prominent Industry Associations from the Pensylvania and New Jersey Pharma ecosystems
+ 55 Qualified Partnership Meetings... with targeted US corporations or Clinical Institutions (list is confidential)
|
|
2011 Light-CT User's Meeting
Tuesday April 5th 2011
NJ Commercialization Center of Innovative Technologies
About the Light-CT
LLTech’s Light-Coherent Tomography (CT) provides digital non-destructive imaging of tissues at the cellular level. As opposed to its competing processes:
-
Light-CT™ uses white light (no lasers) to slice/scan under the surface of the analyzed tissue.
-
It does not require tissue preparation or modification, or staining of any kind
-
The images are created within minutes by a non-destructive process whereas histology (Gold Standard) takes several hours, if not days, with a physical “slicing” of the samples.
-
Images offer a 1 µm cellular resolution in all 3 dimensions and can be reconstructed in 3D
As a result, the Light-CT has the potential to eliminate most of the current equipment used in the Pathology Lab, reduce process steps by more than 50%, eliminate low value add FTEs, standardize imaging, offer a platform for rigorous image scoring, and archiving and enable real time collaboration of pathologists around the world to drive better outcomes, whereas the pathologists are in clinical research, stem cell research or in the hospital.
By displacing a significant cost infrastructure, digitizing major workflows without modifying surgical or clinical protocols, and offering 3D to pathologists, the Light-CT is a disruptive and sought-after technology
About the User's Meeting and Application Lab Grand Opening
8:30 am Gathering, Networking Coffee
9:00 User’s Meeting Opening and Welcome
Bertrand de Poly, CEO, LLTECH, Inc
9:30 The Future of the Light-CTTM
Pr. Claude Boccara, CSO, LLTECH, Inc
10:00 Modified Full-Field OCT: A novel application in Rapid Histology
Manu Jain, MD, Weill Medical College of Cornell University
10:30 Coffee Break
11:00 The Light-CTTM as an adjunct to Histology in the Research Lab
Matt Fronheiser, Ph.D, Biomedical Engineer, Bristol–Myers Squibb
11:30 Image Enrichment and Analysis of Light-CTTM Images
Andrezej Cholewinski, Application Scientist, DEFINIENS
12:30pm LLTech’s US Application Lab Grand Opening
Lunch, Networking and Poster session
PM session and Hands-on the Light-CTTM … Bring your samples
|
|
EU-NJ Business Forum - Life Sciences Industries
Supported by the "Getting to Know Europe" 2011 program
with the Launch of the European-American Chamber of Commerce of New Jersey
When:
March 31st, 2011 , 9am - 1pm
Where:
Heldrich Center for Workforce Development, Rutgers University
Program:
With prominent guest speakers from Industry and Government, the forum will explore opportunities for building research and commercial partnerships, highlight new life-sciences technologies being developed in the EU, and identify recent and anticipated regulated developments in the EU affecting NJ Businesses
|
Program Highlights:
In partnership with Advantage Austria, a series of three events, presented to three groups of MedTech ecosystems, including 2 hours session composed of a presentation followed by an interactive discussion on the following topics:
- Presentation of the major Medical Needs and related demographics in the US
- Recent evolution in the regulatory frameworks related to Convergent Medical Technologies
- Fundamentals of the US Healthcare Economic system
- Presentation of specific opportunities for Entrepreneurs in the Convergence Space
- Presentation of the specific technology partnership needs of major US Corporations
| Program Resources:
- Request Event Presentation : click here
- Conference References materiasl and resources : click here
- Join our blog and share : click here
2011 US CEO MEDTECH CHALLENGE:
- Request Program Brochure : click here
- Apply for Program : click here
|
The Medical Technology Association of New Zealand and the New Zealand Health IT Cluster are delighted to be working in partnership to deliver this conference package which concentrates on the interception between device and IT solutions in healthcare.
On February 14-15, this event will showcase both the New Zealand Emerging Medical Technology sector and the Health IT sector and connect them with both local and international resources of knowledge and expertise. The conference will create invaluable networking and business opportunities.
MedNest's Mathieu Petitjean will deliver a keynote presentation on opportunities for Entrepreneurs in the field of Medical Convergent Technologies in the USA.
Evening Functions
Included in the conference registration is the Research Showcase. Research organisations and universities from around New Zealand will showcase projects with a medical technology focus. This showcase will commence at the end of the conference programme from 5.00pm - 6.30pm and include light refreshments and canapes.
The Hon Gerry Brownlee will provide the Ministerial Address at the conference dinner on Tuesday evening (6.30pm - 11.00pm). We hope you can join us at this reception also.
|
|
2010 US CEO e-Health Forum
June 14-18 2010, Boston, Princeton, NJ, US
MedNest is proud to present 10 e-Health Ventures to the US Markets:
2 Days of targeted workshops..... with Key Note speakers from Connected Healthm GE Healthcare, Microsoft Health, HIMSS, IHE
3 Parnerships events... with prominent Industry Associations such as the Massachussets Medical Device Association ( MassMedic) and the New Jersey Technology Council (NJTC)
55 Qualified Partnership Meetings... with targeted US corporations or Clinical Institutions (list is confidential) resulting in an average of 3.5 qualified business/commercial/partnership leads by company
Featured Companies:
Beep and Track:
The Medical Device Traceability Engine" Website
Bow Medical:
The leading EMR dedicated to the Operating Rooms and Anesthesiologists Website
E-Device:
Connecting Devices" Website
MedImaps:
Extracting Bone microstructure informations and fracture risks from bone densitometry Images. Website
NetInf:
Software Editor who integrates different technical platforms ( GPS, Collaboration, ERP, biometric ID) to enhance healthcare services to individuals.
Telecom Design:
OEM and Add-On Telecommunication Modules for Medical Devices, Diagnostics and Equipments. Website
Domicalis:
A digital solution for the home and the hospital.
Intellitech / Xtractis:
Predictive Data Analysis for the Secondary Use of Healthcare Digital Data. Website
SFRI:
Manufacturer of in vitro diagnostic instruments and reagents (Hematology, Biochemistry, Immunology) with EMR and HCIT interfaces. Website
SkinLabs:
Point of Care imaging and diagnostics for skin care, based on a portable and fully digital Medical Device. Website
With the Support and Sponsorship of:
|
 |
| Mission pour la Science et la Technologie |
|
| | |
|
2009 US CEO MedTech Forum
June 21-24th, 2009, Princeton-Boston, USA
BioNJ, the Chamber of Commerce of Bordeaux, the Aquitaine Region and French Foreign Trade Agency and MedNest join forces to Welcome Emerging Medtech Companies looking for US Partners for a 5 day partnering and in-country business development program.
Press:
Rutgers, N.J. Seeks to develop MedTech "French Connection" and highlights MedNest role as a catalyst (Article)
EDA's International Trade department and MedNest Bring French Investors into NJ, NJ international, Vol 1, Winter 2010
|
|
